Multiple sclerosis: Levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-β-1b treatment

Scandinavian Journal of Immunology

Volumn 49, Issue 5, 1999, Pages 554-561

  Ozenci V ^a   Kouwenhoven, M ^a   Huang, Y M ^a   Xiao, B G ^a   Kivisakk P ^a   Fredrikson, S ^a   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERFERON BETA SERINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; MYELIN BASIC PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; AGED; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-BETA; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; RECOMBINANT PROTEINS;

EID: 0032977543     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1999.00546.x     Document Type: Article

References (43)

1. Panitch HS, Hirsh L, Schindler J, Johnson KP. Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system. Neurology 1987;37:1097-102.
2. Navikas V, Link H. Cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res 1996;45:322-33.
3. Fiorentino D, Bond M, Mossman T. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989;170:2081-5.
4. Mossman T. Properties and functions of interleukin-10. Adv Immunol 1994;56:1-26.
5. Isomaki P, Luukkainen P, Saario R, Toivanen P, Punnonen J. Interleukin functions as an anti-inflammatory cytokine in rheumatoid synovium. Arthritis Rheum 1996;39:386-95.
6. Pennline KJ, Roque-Gaffney E, Monahan M. Recombinant human IL-10 prevents the onset of diabetes in the non-obese diabetic mouse. Clin Immunol Immunopathol 1994;71:169-75.
7. Asadullah K, Sterry W, Stephanek K, Jasulaitis D, Leupold M, Audring H, Volk HD, Docke WD. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest 1998;101:783-94.
8. Rott O, Fleischer B, Cash E. Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 1994;24:1434-40.
9. Kennedy MK, Torrance DS, Picka KS, Mohler KM. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlated with recovery. J Immunol 1992;149:2496-505.
10. Diab A, Zhu J, Xiao BG, Mustafa M, Link H. High IL-6 and low IL-10 in the central nervous system are associated with protracted relapsing EAE in DA rats. J Neuropathol Exp Neurol 1997; 56:641-50.
11. Zhang G-X, Yu L, Xiao B, Link H. Enhancement of EAMG in rat by rhIL-10 is associated with augmented B cell response to AChR. IV International Conference on Cytokines Abstract Book 1997;111.
12. Zhang G-X, Navikas V, Link H. Cytokines and the pathogenesis of myasthenia gravis. Muscle and Nerve 1997;20:543-51.
13. Rodriguez M, Miller DJ. Immune promotion of central nervous system remyelination. Progr Brain Res 1994;103:343-55.
14. Link H. B cells and autoimmunity. In: WC.Russel, ed., Molecular Biology of Multiple Sclerosis. Chichester, UK: John Wiley & Sons, 1997:161-90.
15. Navikas V, Link J, Palasik W, Söderström M, Fredrikson S, Olsson T, Link H. Increased mRNA expression of IL-10 in mononuclear cells in multiple sclerosis and optic neuritis. Scand J Immunol 1995;41:171-8.
16. Crucian B, Dunne P, Friedman H, Ragsdale R, Pross S, Widen R. Alternations in peripheral blood mononuclear cell cytokine production in response to phytohemagglutinin in multiple sclerosis patients. Clin Diagn Lab Immunol 1995;2:766-9.
17. Brod SA, Nelson LD, Khan M, Wolinsky JS. Increased in vitro induced CD4+ T cell IL-10 production in stable relapsing multiple sclerosis. Int J Neurosci 1997;90:187-202.
18. Rieckmann P, Albrecht M, Kitze B, Weber T, Tumani H, Broocks A, Luer W, Poser S. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis. Neurology 1994;44:1523-6.
19. Porrini AM, Gambi D, Reder AT. Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients. J Neuroimmunol 1995;61:27-34.
20. Musette P, Benveniste O, Lim A, Bequet D, Kourilsky P, Dormont D, Gachelin G. The pattern of production of cytokine mRNAs is markedly altered at the onset of multiple sclerosis. Res Immunol 1996;147:435-41.
21. Salmaggi A, Dufour A, Eoli M, Corsini E, La Mantia L, Massa G, Nespolo A, Milanese C. Low serum interleukin levels in multiple sclerosis: further evidence for decreased systemic immunosuppression? J Neurol 1996;243:13-7.
22. The IFNB, Multiple Sclerosis Study Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-85.
23. Porrini AM, Luca G, Gambi D, Reder AT. Effects of an anti-IL-10 monoclonal antibody on rIFN-β-mediated immune modulation. Relevance to multiple sclerosis. J Neuroimmunol 1998;81:109-15.
24. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocoles. Ann Neurol 1983;13:227-31.
25. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33:1444-52.
26. Deibler GE, Martensson RE, Kies MV. Large scale preparation of myelin basic protein from central nervous system tissue from several mammalian species. Prep Biochem 1972;2:139-65.
27. Laemmli UK. Cleavage of structural proteins during assembly of the bacteriophage T4. Nature 1970;227:680-5.
28. Czerkinsky CC, Andersson G, Ekre H-P, Nilsson L-Å, Klareskog L, Ouchterlony Ö. Reverse ELISPOT assay for clinical analysis of cytokine production. I. Enumeration of gamma-interferon secreting cells. J Immunol Methods 1988;110:29-36.
29. Link H, Olsson O, Sun J, Wei-Zhi W, Andersson G, Ekre H-P, Brenner T, Abramsky O, Olsson T. Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest 1991;87:2191-6.
30. Olsson T, Zhi WW, Höjeberg B, Kostulas V, Yu-Ping J, Anderson G, Ekre H-P, Link H. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-γ. J Clin Invest 1990;86:981-5.
31. Sun J-B, Olsson T, Wang W-Z, Xiao B-G, Kostulas V, Fredrikson S, Ekre H-P, Link H. Autoreactive T and B cells responding to myelin proteolipid protein in mulltiple sclerosis and controls. Eur J Immunol 1991;21:1461-8.
32. Hagiwara E, Abbasi F, Mor G, Ishigatsubo Y, Klinman DM. Phenotype and frequency of cells secreting IL-2, IL-4, IL-6, IL-10, IFN-γ and TNF-α in human peripheral blood. Cytokine 1995;7:815-22.
33. Barnes A. Measurements of serum cytokines. Lancet 1998;352: 324-5.
34. Marchant A, Deviere J, Byl B, De Groote D, Vincent J, Goldman M. Interleukin-10 production during septicemia. Lancet 1994;343:707-8.
35. Bendtzen K, Svenson M, Jonsson V, Hippe E. Autoantibodies to cytokines - friends or foes? Immunol Today 1990;5:167-9.
36. Huthings PR, Cambridge G, Tite JP, Meager T, Cooke A. The detection and enumeration of cytokine secreting cells in mice and man and the clinical application of these assays. J Immunol Methods 1989;120:1-8.
37. Shirai A, Holmes K, Klinman DM. Detection and quantitation of cells secreting IL-6 under physiological conditions in BALB/c mice. J Immunol 1993;150:793-9.
38. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178: 1041-8.
39. Howard M, O'Garra A. Biological properties of interleukin 10. Immunol Today 1992;13:198-200.
40. Oswald IP, Wynn TA, Sher A, James SJ. Interkukin-10 inhibits macrophage microbial activity by blocking the endogeneous production of tumor necrosis factor arequired as a costimulatory factor for interferon γ-induced activation. Proc Natl Acad Sci USA 1992;89: 8676-80.
41. Qu ZX, Dayal A, Jensen MA, Arnason BGW. All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis. Arch Neurol 1998;55:315-21.
42. Rudick RA, Ransohoff RM, Peppler R, Van der Brug Medendorp S, Lehmann P, Alam J. Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol 1996;40:618-27.
43. Rudick RA, Ransohoff RM, Lee JC, Peppler R, Yu M, Mathisen PM, Tuohy VK. In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis. Neurology 1998;50:1294-300.